Leukemia inhibitory factor signaling is required for lung protection during pneumonia.
Leukemia inhibitory factor signaling is required for lung protection during pneumonia.
复制标题
DOI：
10.4049/jimmunol.1200256
复制
发表时间：
2012-06-15
期刊：
影响因子：
--
通讯作者：
Allen E
中科院分区：
文献类型：
--
作者：
Quinton LJ;Mizgerd JP;Hilliard KL;Jones MR;Kwon CY;Allen E
Lung infections represent a tremendous disease burden and a leading cause of acute lung injury. STAT3 signaling is essential for controlling lung injury during pneumonia. We previously identified leukemia inhibitory factor (LIF) as a prominent STAT3-activating cytokine expressed in the airspaces of pneumonic lungs, but its physiological significance in this setting has never been explored. To do so, Escherichia coli was intratracheally instilled into C57BL/6 mice in the presence of neutralizing anti-LIF IgG or control IgG. Anti-LIF completely eliminated lung LIF detection and markedly exacerbated lung injury compared to control mice as evidenced by airspace albumin content, lung liquid accumulation, and histological analysis. Although lung bacteriology was equivalent between groups, bacteremia was more prevalent with anti-LIF treatment, suggestive of compromised barrier function rather than impaired antibacterial defense as the cause of dissemination. Inflammatory cytokine expression was also exaggerated in anti-LIF-treated lungs, albeit after injury had ensued. Interestingly, alveolar neutrophil recruitment was modestly but significantly reduced compared to control mice despite elevated cytokine levels, indicating that inflammatory injury was not a consequence of excessive neutrophilic alveolitis. Lastly, the lung transcriptome was dramatically remodeled during pneumonia, but far more so following LIF neutralization, with gene changes implicating cell death and epithelial homeostasis amongst other processes relevant to tissue injury. From these findings, we conclude that endogenous LIF facilitates tissue protection during pneumonia. The LIF-STAT3 axis is here identified as a critical determinant of lung injury with clinical implications for pneumonia patients.
登录
查看更多内容
DOI：
10.4049/jimmunol.0903843
发表时间：
2010-11-15
期刊：
Journal of immunology (Baltimore, Md. : 1950)
影响因子：
--
作者：
Cai S;Batra S;Lira SA;Kolls JK;Jeyaseelan S
通讯作者：
Jeyaseelan S
影响因子：
3.8
作者：
Heymann, D;LHer, E;Godard, A
通讯作者：
Godard, A
DOI：
10.4161/cc.8.9.8348
发表时间：
2009-05-01
期刊：
Cell cycle (Georgetown, Tex.)
影响因子：
--
作者：
Gao W;Thompson L;Zhou Q;Putheti P;Fahmy TM;Strom TB;Metcalfe SM
通讯作者：
Metcalfe SM
影响因子：
20.3
作者：
Gregory, Alyssa D.;Hogue, Lisa A.;Link, Daniel C.
通讯作者：
Link, Daniel C.
影响因子：
6
作者：
Kida, Hiroshi;Mucenski, Michael L.;Whitsett, Jeffrey A.
通讯作者：
Whitsett, Jeffrey A.